The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as ...

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

Top officials for the Food and Drug Administration laid out new requirements ... to COVID-19 vaccines, similar to the annual flu shot. Just like with flu vaccines, until now the FDA has approved ...

Critics fear that U.S. Department of Health and Human Services chief RFK, Jr., known for his antivaccine views, has picked a ...

U.S. health officials, following recommendations by infectious disease experts, have been urging annual COVID-19 boosters for ...

The abrupt termination of the 17 panelists guiding the CDC’s vaccine recommendations could yield a new committee more aligned ...

Kennedy's move appears to shortcut the CDC's outside vaccine advisers, dropping COVID vaccines from the list recommended for ...

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...

Robert F. Kennedy Jr. announced a panel including vaccine skeptics, drawing criticism from public health leaders and misinformation watchdogs.

The U.S. approved a new COVID-19 vaccine ... them at increased risk from the coronavirus. That’s the same limit the FDA set in licensing another COVID-19 vaccine option from competitor Novavax.